NPI: 1659844405 · COLUMBUS, MS 39705 · Rural Health Clinic/Center · NPI assigned 01/04/2019
Authorized official SINGH, KIRNJOT controls 20+ related entities in our dataset. Read more
| Authorized Official | SINGH, KIRNJOT (PRESIDENT) |
| NPI Enumeration Date | 01/04/2019 |
Other providers sharing the same authorized official: SINGH, KIRNJOT
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 175 | $1K |
| 2020 | 4,886 | $93K |
| 2021 | 5,678 | $216K |
| 2022 | 2,774 | $138K |
| 2023 | 1,341 | $77K |
| 2024 | 811 | $44K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11,262 | 9,273 | $507K |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 3,635 | 3,513 | $50K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 260 | 233 | $6K |
| 99441 | 133 | 115 | $2K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16 | 14 | $1K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 20 | 17 | $656.25 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 19 | 15 | $466.18 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 18 | 16 | $412.00 |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 51 | 51 | $274.89 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 19 | 17 | $223.76 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 44 | 42 | $116.40 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 100 | 92 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 88 | 80 | $0.00 |